ArticleFrontiers in public health2022
Antimicrobial resistance and genomic investigation of non-typhoidal
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- Invasive non-typhoidal Salmonella infections in China (1961-2024): a retrospective systematic analysis of multicentre case reports.Journal of global health · 2026Pooled it
- One Health genomics reveals niche-specific lineage replacement inNational science review · 2026Article
- Antimicrobial resistance and genomic characteristics of nontyphoidal Salmonella strains from diarrheal patients in Shandong, China.Gut pathogens · 2026Article
- Non-typhoidalItalian journal of food safety · 2026Article
- Genomic characterization ofFrontiers in microbiology · 2026Article
- Genomic epidemiology ofFrontiers in microbiology · 2026Article
- Antibiotic Resistance Trends and Prescribing Patterns in Pediatric Non-TyphoidalInfection and drug resistance · 2026Article
- Molecular epidemiology of pESI-carryingEmerging microbes & infections · 2025Article
- Emergence of carbapenem-resistantMicrobiology spectrum · 2025Article
- Serovar-Specific Antimicrobial Resistance and Virulence Profiles of Salmonella enterica From Poultry in Bangladesh.MicrobiologyOpen · 2025Article
- Genomic census of invasive nontyphoidal Salmonella infections reveals global and local human-to-human transmission.Nature medicine · 2025Article
- Antimicrobial Resistance and Genomic Characterization of Salmonella Serovars Typhimurium and 4,[5],12:i:- in Huzhou, China.Infection and drug resistance · 2025Article
- Stool carriage of CTX-M/CMY-producingFrontiers in cellular and infection microbiology · 2025Article
- AI-2 Signaling: A Potential Driver of Bacteremia in Non-TyphoidalInfection and drug resistance · 2025Article
- The Evolution of Vaccines Development acrossVaccines · 2024Review
- Genomic analysis of antibiotic resistance genes and mobile genetic elements in eight strains of nontyphoidmSystems · 2024Article
- Isolation, Identification, Antimicrobial Resistance, Genotyping, and Whole-Genome Sequencing Analysis ofPolish journal of microbiology · 2024Article
- Molecular Characteristics ofInfection and drug resistance · 2024Article
- Antimicrobial Resistance and Genomic Characterization ofTransboundary and emerging diseases · 2024Article
- Antimicrobial resistance and genomic investigation ofFrontiers in microbiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human non-typhoidal salmonellosis is among the leading cause of morbidity and mortality worldwide, resulting in huge economic losses and threatening the public health systems. To date, epidemiological characteristics of non-typhoidal
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.